Kewaunee Scientific financials
$34.00−0.06%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '27 Jul 31 | Q4 '26 Apr 30 | Q3 '26 Jan 31 | Q2 '26 Oct 31 | Q1 '26 Jul 31 | Q4 '25 Apr 30 | Q3 '25 Jan 31 | Q2 '25 Oct 31 | Q1 '25 Jul 31 | Q4 '24 Apr 30 | Q3 '24 Jan 31 | Q2 '24 Oct 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66.3M | $71.4M | $69.4M | $70.1M | $71.1M | $77.1M | $67.2M | $47.8M | $48.4M | $56.7M | $46.8M | $50.4M |
| Gross profit | $19.6M | $21.2M | $18.5M | $19.7M | $20.9M | $24.0M | $18.4M | $14.0M | $12.5M | $14.6M | $12.0M | $13.5M |
| Gross margin | 29.6% | 29.8% | 26.7% | 28.1% | 29.4% | 31.2% | 27.4% | 29.2% | 25.8% | 25.8% | 25.7% | 26.7% |
| Operating income | $3.2M | $5.2M | $2.6M | $4.1M | $4.8M | $8.5M | $2.3M | $4.4M | $2.6M | $5.7M | $3.8M | $5.1M |
| Net income | $1.7M | $3.4M | $692.0K | $2.4M | $3.1M | $4.8M | $1.4M | $3.0M | $2.2M | $11.0M | $2.5M | $2.7M |
| Net margin | 2.6% | 4.7% | 1.0% | 3.5% | 4.3% | 6.3% | 2.0% | 6.3% | 4.5% | 19.4% | 5.4% | 5.4% |
| Diluted EPS | $0.58 | $1.13 | $0.23 | $0.82 | $1.04 | $1.63 | $0.45 | $1.01 | $0.74 | $3.71 | $0.85 | $0.93 |
| EBITDA | $4.7M | $7.3M | $4.2M | $5.7M | $6.4M | $10.3M | $3.8M | $5.2M | $3.4M | $6.5M | $4.6M | $5.9M |
| Operating cash flow | $2.0M | $5.5M | $11.6M | -$4.3M | $5.8M | $9.4M | -$2.3M | $8.4M | -$794.0K | $1.1M | $9.5M | $747.0K |
| Free cash flow | $1.2M | $4.5M | $11.0M | -$5.8M | $5.0M | $8.9M | -$3.0M | $7.8M | -$1.1M | $166.0K | $9.0M | -$518.0K |
| Diluted shares | 2.9M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M | 2.9M |
Balance sheet
| Period end | Jul 31 | Apr 30 | Jan 31 | Oct 31 | Jul 31 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.2M | $9.9M | $8.2M | $12.6M | $19.5M | $14.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $45.9M | $46.8M | $49.7M | $63.1M | $64.6M | $65.4M |
| Total assets | $175.8M | $178.3M | $176.0M | $189.1M | $193.5M | $194.7M |
| Total liabilities | $98.6M | $101.5M | $103.4M | $117.4M | $124.6M | $128.4M |
| Shareholders' equity | $77.2M | $76.8M | $72.5M | $71.7M | $68.9M | $66.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology